Objectif The sterilization of medical devices (such as implants, artificial joints, syringes, blood bags), as well as ‘tetrapacks’, food packaging, and even wine corks, is currently performed by third-parties. This adds time and costs to the final and critical part of the manufacturing process. Many new medical devices cannot be sterilized through radiation and can only be sterilized through chemical gas processes that results in harmful gases remaining in the packaging which can be harmful to end users of the products such as hospital staff. Moreover, medical device sterilization is currently not properly documented and controlled, often causing broad product recalls should a single product be found to be non-sterile. This adds further expense and delay due to the need to repeat the sterilization process. EnXray has developed an innovative sterilization machine that delivers high efficiency ionizing radiation, using low energy Xray’s to reach the Sterility Assurance Level, in an affordable manner enabling safe on-site and on-demand sterilization of medical devices. It can be installed on site at each production facility helping manufacturing companies to reduce production costs and times. Furthermore, the current inventory holding costs incurred by medical device manufacturing companies could be reduced substantially by EnXray’s technology thanks to the reliable sterilisation process. Within the overall project EnXray intend to optimise the commercial design according to medical partner requirements, demonstrate it for use in converyor processing, develop a better understanding of its impact on new plastic materials as well as fully establish the commercialisation strategy. Champ scientifique engineering and technologymechanical engineeringmanufacturing engineeringnatural sciencesphysical sciencesnuclear physicsnatural sciencesearth and related environmental sciencesenvironmental sciencespollutionengineering and technologyother engineering and technologiesfood technologyfood packagingmedical and health sciencesmedical biotechnologyimplants Programme(s) H2020-EU.2.1.2. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies Main Programme H2020-EU.2.1.5. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing H2020-EU.2.1.3. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument Thème(s) SMEInst-02-2016-2017 - Accelerating the uptake of nanotechnologies advanced materials or advanced manufacturing and processing technologies by SMEs Appel à propositions H2020-SMEInst-2016-2017 Voir d’autres projets de cet appel Sous appel H2020-SMEINST-1-2016-2017 Régime de financement SME-1 - SME instrument phase 1 Coordinateur ENXRAY LIMITED Contribution nette de l'UE € 50 000,00 Adresse LIVERPOOL INNOVATION PARK EDGE LANE L7 9NJ LIVERPOOL Royaume-Uni Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région North West (England) Merseyside Liverpool Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 71 429,00